hengrui glp-1 Hengrui, Kailera's oral clears late-stage bar in China but US results still pending Hengrui/Kailera's GLP-1 Pill Proves Class-Competitive

We do have some clients in our community that are on GLP-1 RAs

"With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need." According to Eli Lilly, adults in the Phase 3 trials all lost weight with orforglipron and on the highest dose of 36 mg of orforglipron, the trial participants lost about 27 pounds over the course of 72 weeks or about 12% of their body weight, which is meaningful but not quite as high as some injectables

Cutting-edge technology and detailed pre-op planning give patients more predictable outcomes, fewer complications, and easier recovery

Anaesth Rep 2024;12:e12278.ArticlePubMedPMC 18